Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma

By Li He-cheng   Cao Dao-cheng   Liu Yi   Hou Yi-feng   Wu Jiong   Lu Jin-song   Di Gen-hong   Liu Gang   Li Fang-ming   Ou Zhou-luo   Jie Cui   Shen Zhen-zhou   Shao Zhi-ming  

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

By Fehm T.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite

Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer Patients

By Lüftner D.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers

By Horio Akiyo  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Behaviour of metastasis in relation to vascular index in patients with node-positive breast cancer treated with adjuvant tamoxifen

By Gasparini Giampietro   Fanelli Massimo   Boracchi Patrizia   Morabito Alessandro   Locopo Nathalia   Biganzoli Elia  

Clinical and Experimental Metastasis, Vol. 18, Iss. 1, 2000-01 ,pp. : 15-20

Springer Publishing Company

Access to resources Recommend Favorite